...
首页> 外文期刊>American Journal of Ophthalmology: The International Journal of Ophthalmology >Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration
【24h】

Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration

机译:黄斑部视网膜下组织纤溶酶原激活物和气压置换治疗老年性黄斑变性

获取原文
获取原文并翻译 | 示例

摘要

? Purpose: To evaluate the outcome of pars plana vitrectomy, subretinal tissue plasminogen activator (t-PA) infusion and intraocular gas tamponade with and without postsurgical antivascular endothelial growth factor (VEGF) injection for thick submacular hemorrhage due to exudative age-related macular degeneration (AMD). ? Design: Retrospective, comparative, interventional case series. ? Methods: setting: 2 retina referral centers. The patient population included 101 eyes of 101 patients with neovascular AMD and thick submacular hemorrhage who underwent surgical displacement of the hemorrhage with or without postoperative anti-VEGF injections. Main outcome measures included degree of blood displacement, best and final postoperative visual acuity (VA), and adverse events. Snellen acuity was converted to logMAR for statistical analysis. ? Results: All patients were followed for a minimum of 3 months (mean, 15.3 months, range, 3-70 months). In 83 (82%) of 101 eyes, the procedure resulted in complete hemorrhage displacement from the fovea. Mean preoperative VA was 20/2255 (2.05 logMAR). The acuity significantly improved to 20/893 (1.65 logMAR) at month 1 (P < 0.001) at month 1; 20/678 (1.53 logMAR) at month 3 (P < 0.001), and 20/1150 (1.76 logMAR) at month 12 (P = 0.002). Best postoperative visual acuity improved by at least 1 line in 83 (82%) of 101 eyes, and 19.6% of eyes gained 3 lines or more at month 3. The visual acuity of the group of eyes that received postoperative anti-VEGF injection (n = 39) showed greater visual acuity improvement 6 months postoperatively compared to the group of eyes that did not receive postoperative anti-VEGF. Postoperative complications included vitreous hemorrhage in 2 eyes, rhegmatogenous retinal detachment in 4 eyes, and recurrent thick subretinal hemorrhage in 6 eyes. ? Conclusions: Vitrectomy with subretinal t-PA injection and gas tamponade was found to be relatively effective for displacement of thick submacular hemorrhage with a significant improvement in visual acuity. There is a loss of acuity over time; the addition of postoperative anti-VEGF therapy may help maintain the visual acuity gains.
机译:?目的:评估平面玻璃体切除术,视网膜下组织纤溶酶原激活剂(t-PA)输注和眼内气体压塞加或不加术后抗血管内皮生长因子(VEGF)注射治疗因渗出性年龄相关性黄斑变性而引起的严重黄斑下出血的结果( AMD)。 ?设计:回顾性,比较性,介入性病例系列。 ?方法:设置:2个视网膜转诊中心。该患者人群包括101例新血管性AMD并伴有黄斑下严重出血的患者中的101眼,这些患者在接受或不接受术后抗VEGF注射的情况下进行了手术置换。主要结局指标包括血液置换程度,最佳和最终术后视力(VA)以及不良事件。将Snellen敏锐度转换为logMAR进行统计分析。 ?结果:所有患者均接受了至少3个月的随访(平均15.3个月,范围3-70个月)。在101只眼中有83只(82%)的手术导致黄斑中央凹完全出血。术前平均VA为20/2255(2.05 logMAR)。第1个月的视力显着提高到20/893(1.65 logMAR)(P <0.001);第3个月时为20/678(1.53 logMAR)(P <0.001),第12个月时为20/1150(1.76 logMAR)(P = 0.002)。 101眼中的83眼(82%)的最佳术后视力至少提高了1线,而在第3个月时,有19.6%的眼获得了3线或更高。接受术后抗VEGF注射的那组眼睛的视力( n = 39)与未接受术后抗VEGF的那组眼睛相比,术后6个月的视力有了更大的改善。术后并发症包括玻璃体出血2眼,流源性视网膜脱离4眼和复发性视网膜下增厚出血6眼。 ?结论:玻璃体切除术联合视网膜下t-PA注射和填塞性气体填塞被认为对置换厚性黄斑下出血相对有效,并且视力有显着改善。随着时间的流逝,视力会下降;术后补充抗VEGF治疗可能有助于维持视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号